Table 1.
Clinicopathological characteristics of all patients
| Characteristics | Total series (n=90) |
|---|---|
|
| |
| Age groups (years) | |
| ≤60 | 42 (47%) |
| >60 | 48 (53%) |
| FIGO stage | |
| III | 64 (71%) |
| IV | 26 (29%) |
| Histology Serous | 71 (79%) |
| Mucinous | 6 (7%) |
| Endometrioid/clear cells | 13 (14%) |
| AACI category | |
| AACI 0 | 35 (39%) |
| AACI 1–3 | 25 (28%) |
| AACI 4–8 | 30 (33%) |
| Computed tomography PCI category | |
| 1–10 | 47 (52%) |
| >10 | 43 (48%) |
| CEA* | 1.3 (0.8–2) |
| CA199* | 15.9 (3–38) |
| CA125* | 197 (58–638) |
| CA153* | 34 (16–101) |
| Laparoscopic PCI category | |
| 1–10 | 22 (24%) |
| >10 | 68 (76%) |
| Operative PCI category | |
| 1–10 | 40 (44%) |
| >10 | 50 (56%) |
| Number of visceral resections | |
| 0 | 12 (13%) |
| 1 | 17 (19%) |
| 2 | 19 (21%) |
| 3 | 11 (12%) |
| 4 | 6 (7%) |
| 5 | 7 (8%) |
| 6 | 5 (6%) |
| 7 | 3 (3%) |
| 8 | 5 (6%) |
| 9 | 1 (1%) |
| 11 | 2 (2%) |
| 13 | 1 (1%) |
| 14 | 1 (1%) |
| Visceral resections | |
| Rectum | 29 (32%) |
| Colon | 66 (73%) |
| Bowel | 23 (26%) |
| Urinary bladder | 14 (16%) |
| Ureter | 5 (6%) |
| Stomach | 6 (7%) |
| Pancreas | 8 (9%) |
| Spleen plus pancreas | 26 (29%) |
| Gallbladder | 22 (24%) |
| Liver | 6 (7%) |
| Glisson | 15 (17%) |
| Diaphragm | 12 (13%) |
| Major vessels | 3 (3%) |
| Residual tumor | |
| CCS | 74 (82%) |
| OCS | 5 (6%) |
| SCS | 11 (12%) |
| Postoperative stay* | 17 (11–31) |
Note:
*
Median (IQR).
Abbreviations: AACI, Age-adjusted Charlson Comorbidity Index; CA, carbohydrate antigen; CCS, complete cytoreductive surgery (no residual macroscopic tumor); CEA, carcinoembryonic antigen; FIGO, International Federation of Obstetrics and Gynecology; OCS, optimal cytoreductive surgery (residual tumor <1 cm in diameter); PCI, Peritoneal Cancer Index; SCS, suboptimal cytoreductive surgery (residual tumor >1 cm in diameter).